API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.fiercebiotech.com/biotech/soligenxs-stock-sinks-36-after-fda-refuses-consider-lymphoma-therapy-application
https://www.clinicaltrialsarena.com/news/soligenix-patient-enrolment-trial-psoriasis/
https://www.clinicaltrialsarena.com/news/soligenix-patient-enrolment-trial-psoriasis/
https://www.prnewswire.com/news-releases/soligenix-receives-fda-ind-clearance-for-phase-2-clinical-trial-of-synthetic-hypericin-in-the-treatment-of-psoriasis-301575751.html
https://www.biospace.com/article/releases/soligenix-to-advance-synthetic-hypericin-development-in-psoriasis/?s=71
https://www.prnewswire.com/news-releases/soligenix-announces-recent-accomplishments-and-first-quarter-2020-financial-results-301059720.html
https://www.prnewswire.com/news-releases/soligenix-announces-positive-top-line-results-for-its-pivotal-phase-3-flash-trial-evaluating-sgx301-in-treatment-of-cutaneous-t-cell-lymphoma-301026468.html
https://www.biospace.com/article/releases/soligenix-receives-us-patent-for-improved-production-of-synthetic-hypericin-composition/?s=95